Guger, M; Enzinger, C; Leutmezer, F; Kraus, J; Berger, T. Real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian Multiple Sclerosis Treatment Registry MULT SCLER J. 2014; 20: 198-198. Web of Science